UPDATE: BioLineRx (BLRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
(Updated - November 21, 2017 7:06 AM EST)
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Columbia Financial, Inc. Announces Preliminary Subscription Offering Results and Increase in Maximum Purchase Limits
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
